Precision Medicine Is Critical for the Future of Oncology: Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on Theranostics, Imaging, and the Urgency to Innovate
Related Posts
Pogosyan A, Liu Y, Patel JA, Mahmoudi M, Xu H, Finn JP, Nguyen KL. Iron-Based Contrast for the Heart: Clinical Promise of Ferumoxytol-Enhanced CMR. Curr[...]
Song MR, Ziaeian B. A New Frontier in Heart Failure: Promise and Pitfalls of Primary Prevention. JACC Heart Fail. 2026 Oct 28:103489. doi: 10.1016/j.jchf.2026.103489. Epub[...]
Sonni I, Mohammadigoldar Z, Furey G, Kimura K, Movva PC, Holzgreve A, Bahri S, Sevco T, Chung A, Sisk A, Grogan T, Czernin J, Sung[...]